Cargando…

High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention

OBJECTIVE: To examine the performances of an alternative strategy to decide initiating BP-lowering drugs called Proportional Benefit (PB). It selects candidates addressing the inequity induced by the high-risk approach since it distributes the gains proportionally to the burden of disease by genders...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchant, Ivanny, Boissel, Jean-Pierre, Nony, Patrice, Gueyffier, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631497/
https://www.ncbi.nlm.nih.gov/pubmed/26529507
http://dx.doi.org/10.1371/journal.pone.0140793
_version_ 1782398875112308736
author Marchant, Ivanny
Boissel, Jean-Pierre
Nony, Patrice
Gueyffier, François
author_facet Marchant, Ivanny
Boissel, Jean-Pierre
Nony, Patrice
Gueyffier, François
author_sort Marchant, Ivanny
collection PubMed
description OBJECTIVE: To examine the performances of an alternative strategy to decide initiating BP-lowering drugs called Proportional Benefit (PB). It selects candidates addressing the inequity induced by the high-risk approach since it distributes the gains proportionally to the burden of disease by genders and ages. STUDY DESIGN AND SETTING: Mild hypertensives from a Realistic Virtual Population by genders and 10-year age classes (range 35–64 years) received simulated treatment over 10 years according to the PB strategy or the 2007 ESH/ESC guidelines (ESH/ESC). Primary outcomes were the relative life-year gain (life-years gained-to-years of potential life lost ratio) and the number needed to treat to gain a life-year. A sensitivity analysis was performed to assess the impact of changes introduced by the ESH/ESC guidelines appeared in 2013 on these outcomes. RESULTS: The 2007 ESH/ESC relative life-year gains by ages were 2%; 10%; 14% in men, and 0%; 2%; 11% in women, this gradient being abolished by the PB (relative gain in all categories = 10%), while preserving the same overall gain in life-years. The redistribution of benefits improved the profile of residual events in younger individuals compared to the 2007 ESH/ESC guidelines. The PB strategy was more efficient (NNT = 131) than the 2013 ESH/ESC guidelines, whatever the level of evidence of the scenario adopted (NNT = 139 and NNT = 179 with the evidence-based scenario and the opinion-based scenario, respectively), although the 2007 ESH/ESC guidelines remained the most efficient strategy (NNT = 114). CONCLUSION: The Proportional Benefit strategy provides the first response ever proposed against the inequity of resource use when treating highest risk people. It occupies an intermediate position with regards to the efficiency expected from the application of historical and current ESH/ESC hypertension guidelines. Our approach allows adapting recommendations to the risk and resources of a particular country.
format Online
Article
Text
id pubmed-4631497
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46314972015-11-13 High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention Marchant, Ivanny Boissel, Jean-Pierre Nony, Patrice Gueyffier, François PLoS One Research Article OBJECTIVE: To examine the performances of an alternative strategy to decide initiating BP-lowering drugs called Proportional Benefit (PB). It selects candidates addressing the inequity induced by the high-risk approach since it distributes the gains proportionally to the burden of disease by genders and ages. STUDY DESIGN AND SETTING: Mild hypertensives from a Realistic Virtual Population by genders and 10-year age classes (range 35–64 years) received simulated treatment over 10 years according to the PB strategy or the 2007 ESH/ESC guidelines (ESH/ESC). Primary outcomes were the relative life-year gain (life-years gained-to-years of potential life lost ratio) and the number needed to treat to gain a life-year. A sensitivity analysis was performed to assess the impact of changes introduced by the ESH/ESC guidelines appeared in 2013 on these outcomes. RESULTS: The 2007 ESH/ESC relative life-year gains by ages were 2%; 10%; 14% in men, and 0%; 2%; 11% in women, this gradient being abolished by the PB (relative gain in all categories = 10%), while preserving the same overall gain in life-years. The redistribution of benefits improved the profile of residual events in younger individuals compared to the 2007 ESH/ESC guidelines. The PB strategy was more efficient (NNT = 131) than the 2013 ESH/ESC guidelines, whatever the level of evidence of the scenario adopted (NNT = 139 and NNT = 179 with the evidence-based scenario and the opinion-based scenario, respectively), although the 2007 ESH/ESC guidelines remained the most efficient strategy (NNT = 114). CONCLUSION: The Proportional Benefit strategy provides the first response ever proposed against the inequity of resource use when treating highest risk people. It occupies an intermediate position with regards to the efficiency expected from the application of historical and current ESH/ESC hypertension guidelines. Our approach allows adapting recommendations to the risk and resources of a particular country. Public Library of Science 2015-11-03 /pmc/articles/PMC4631497/ /pubmed/26529507 http://dx.doi.org/10.1371/journal.pone.0140793 Text en © 2015 Marchant et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Marchant, Ivanny
Boissel, Jean-Pierre
Nony, Patrice
Gueyffier, François
High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
title High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
title_full High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
title_fullStr High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
title_full_unstemmed High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
title_short High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
title_sort high risk versus proportional benefit: modelling equitable strategies in cardiovascular prevention
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631497/
https://www.ncbi.nlm.nih.gov/pubmed/26529507
http://dx.doi.org/10.1371/journal.pone.0140793
work_keys_str_mv AT marchantivanny highriskversusproportionalbenefitmodellingequitablestrategiesincardiovascularprevention
AT boisseljeanpierre highriskversusproportionalbenefitmodellingequitablestrategiesincardiovascularprevention
AT nonypatrice highriskversusproportionalbenefitmodellingequitablestrategiesincardiovascularprevention
AT gueyffierfrancois highriskversusproportionalbenefitmodellingequitablestrategiesincardiovascularprevention